F-FDG PET/CT demonstrates a hypermetabolic pulmonary nodule in the right upper lobe with a maximal standardized uptake value (SUV max ) of 5.3 (a-b, e, empty arrows) and another mild focal 18 F-FDG uptake in the left upper lobe with a SUV max of 2.9 (c-e, arrow heads), also suggestive of metastasis or malignancy in the left upper lobe. Multiple hypermetabolic lymph nodes are noted in the right lower paratracheal and subcarinal space, likely indicating lymph nodes metastasis (e). Histopathological analysis of the wedge-resected biopsies of both upper lobes reveal moderately differentiated adenocarcinoma in the right upper lobe and Langerhans cell histiocytosis (LCH) positive for CD1a and S-100 protein in the left upper lobe (f; ×1.25, g; ×400, hematoxylin and eosin stain, h; ×400, CD1a immunohistochemical stain). After the diagnosis, right upper lobectomy and mediastinal lymph node dissection were performed. The pathologic stage of lung cancer was T1aN2M0 (stage IIIA). LCH is rare and can be distinguished by unrestrained Langerhans cell proliferation and infiltration of various organs [1, 2] . Pulmonary Langerhans cell histiocytosis (PLCH) usually occurs in adult smokers but can be part of a multiorgan disease [1, 3] . Based on epidemiologic data in Japan, the estimated crude prevalences of PLCH in males and females are 0.27 and 0.07 per 100,000 [4] . The symptoms of PLCH are non-specific and include dyspnea, cough, and chest pains. Because it has characteristic findings on chest CT (nodules and cysts predominantly in the upper lung zones with relative sparing of the lung base), PLCH is usually diagnosed by imaging [5] [6] [7] F-FDG uptake on PET may yield false-positive findings in patients with cancer. PLCH coexisting with lung cancer is quite rare, and the association between the two is still unclear [9] [10] [11] . Few cases of coexisting lung cancer and PLCH without extrapulmonary lesions on 18 F-FDG PET/CT have been reported. To the best of our knowledge, the present case may be the first report to observe PCLH presenting as a single nodule simultaneously with lung cancer in the contralateral lobe, mimicking metastasis or double primary malignancy in both chest CT and 
